View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Heineken Holding N.V. reports transactions under its current share buy...

Heineken Holding N.V. reports transactions under its current share buyback programme Heineken Holding N.V. reports transactions under its current share buyback programme Amsterdam, 10 November 2025 - Heineken Holding N.V. (EURONEXT:HEIO; OTCQX: HKHHY), hereby reports transaction details related to the first tranche of up to circa €375 million tranche of its share buyback programme of up to circa €750 million as communicated on 12 February 2025. From 3 November 2025 up to and including 7 November 2025 a total of 97,519 shares were repurchased on exchange at an average price of € 59.80. ...

VRS RESEARCH TEAM
  • VRS RESEARCH TEAM

LEGRAND S.A. Flash Note

Legrand SA, formerly Legrand SNC, is a France-based company. The Company predominantly specializes in electrical and digital building infrastructure. Its range of products are suitable for the commercial, industrial, and residential segments of the low voltage market. The Company has commercial and industrial operations in over 90 countries.

 PRESS RELEASE

Legrand Acquires Avtron Power Solutions, a Global Provider of Load Ban...

Legrand Acquires Avtron Power Solutions, a Global Provider of Load Banks & Power Quality Solutions WEST HARTFORD, Conn., Nov. 07, 2025 (GLOBE NEWSWIRE) -- , a global leader in electrical and digital building infrastructures, announced that it has acquired , a leading global provider of load banks and power quality solutions that serve a wide range of high-growth markets where reliable delivery of power is required. Avtron employs 600 people, operates five sites across North America and Europe, and is expected to generate nearly $350 million in revenue in 2025. With a commitment to innovat...

 PRESS RELEASE

Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study m...

Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase 3 data to be presented at ACAAI demonstrate Dupixent significantly reduced key nasal signs and symptoms including sinus opacification, nasal congestion, and nasal polyps in patients a...

 PRESS RELEASE

Communiqué de presse : ACAAI : L’étude pivot Dupixent menée par Sanofi...

Communiqué de presse : ACAAI : L’étude pivot Dupixent menée par Sanofi et Regeneron a atteint l’ensemble de ses critères d’évaluation principaux et secondaires, réduisant les signes et symptômes de la rhinosinusite fongique allergique... ACAAI : L’étude pivot Dupixent menée par Sanofi et Regeneron a atteint l’ensemble de ses critères d’évaluation principaux et secondaires, réduisant les signes et symptômes de la rhinosinusite fongique allergique ; la demande supplémentaire de licence de mise sur le marché (sBLA) a été acceptée pour examen prioritaire par la FDA Les données de phase 3 qui v...

Delphine Brault ... (+2)
  • Delphine Brault
  • Nathan Mietlicki
Delphine Brault ... (+2)
  • Delphine Brault
  • Nathan Mietlicki

Solvay SA: 1 director

A director at Solvay SA bought 2,000 shares at 25.000EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Adecco: 3Q25 strong beat; outlook 4Q25 seems in line. Air France-KLM: Bit light but outlook unchanged. ArcelorMittal: In line 3Q25, supportive medium-term outlook. AMG: 3Q25 EBITDA beats by 5%, ‘only' modest FY guidance increase might disappoint. BAM Group: Maintains outlook as expected. CTP: Guidance at the lower end due to a missed deal in Romania. Strong operational trends continued. IMCD: 3Q showed pressure on gross margin. Kinepolis: US peer AMC; better revenues and EBITDA in ...

Stefano Toffano
  • Stefano Toffano
Chaima Ferrandon ... (+2)
  • Chaima Ferrandon
  • Sven Edelfelt
Wim Hoste
  • Wim Hoste

Solvay FIRST LOOK: 3Q underl. EBITDA supported by sale of CO2 emission...

3Q underlying EBITDA was 12% better than our forecast and 14% above consensus but was supported by the sale of CO2 emission rights. Excluding this impact, 3Q underlying EBITDA would have been 8% below our forecast and 5% below consensus. Whilst future sales of CO2 emission rights are a possibility, this will mainly depend on future soda ash production levels in Europe and the overall competitive pressures within the soda ash market. Solvay reiterated the FY25 underlying EBITDA guidance of € 880-...

Guy Sips ... (+8)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Lynn Hautekeete
  • Thibault Leneeuw
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Morning Notes : AED BB, COFB BB, GLPG NA, JEN BB, SOLB BB, VGP BB, SHU...

: AED BB, COFB BB, GLPG NA, JEN BB, SOLB BB, VGP BB, SHUR BB, CTPNV NA, IMCD NA, SYENS BB

Chaima Ferrandon ... (+2)
  • Chaima Ferrandon
  • Sven Edelfelt
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch